Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...

An age-old battle in pharmaceuticals could further rattle Eli Lilly stock and its potential $100 billion market in weight-loss drugs.

As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according ...

Pharmaceutical giants Eli Lilly and Company & Novo Nordisk A/S face challenges in the obesity market despite promising data.

A NEW weight loss jabs dubbed the “King Kong” is set to hit the Irish market as soon as next year. Mounjaro can be used to ...

The Alliance for Pharmacy Compounding rebutted Novo's FDA petition to bar compounding pharmacies from copying its weight loss ...

After deciding that tirzepatide was no longer in short supply ... of legal cases involving compounded weight-loss drugs, with Novo Nordisk and Lilly both filing lawsuits seeking to block the ...

Brooks admitted that when she was taking Ozempic she 'lost a little bit of the motivation and the strength to work out.' ...

In a 2019 production of his eponymous show, Mehmet Oz extolled the transformational results of Ozempic in an interview with ...

Hollywood’s latest “miracle drug” was no longer confined to the elite. Despite its reputation as the “Hollywood weight loss drug ... and Saxenda, and Eli Lilly’s Zepbound – are ...

Sharecare said Oz no longer has a financial ... him to lead CMS.” The weight-loss drug debate The Danish-headquartered Novo Nordisk and its U.S.-based rival, Eli Lilly, which manufactures ...

The team remains bullish on Eli Lilly's leadership in the weight-loss market and believes its promising drug pipeline serves ... Yet, there’s no shortage of challenges awaiting Ramji.